Literature DB >> 33846881

Nanoparticles approaches in neurodegenerative diseases diagnosis and treatment.

Zahra Asefy1, Sirus Hoseinnejhad2, Zaker Ceferov3.   

Abstract

The World Health Organization (WHO) has declared that neurodegenerative diseases will be the biggest health issues of the twenty-first century. Among these, Alzheimer's and Parkinson's diseases can be considered as the most acute incurable neurological diseases. Researchers are studying and developing a new treatment approach that uses nanotechnology to diagnosis and treatment neurodegenerative diseases. This treatment strategy will be used to regress neurodegenerative diseases such as Alzheimer's disease. Alzheimer's disease (AD) is one of the most common forms of reduced brain function, which causes many devastating complications. Current neurodegenerative diseases treatment protocols only help to treat symptoms nevertheless with nanotechnology approaches, can regress nerve cells apoptosis, reduce inflammation, and improve brain drug delivery. In this paper, new nanotechnology methods such as nanobodies, nano-antibodies, and lipid nanoparticles have been investigated. Correspondingly blood-brain barrier drug delivery improvement methods have been suggested.

Entities:  

Keywords:  Nanoparticles; Neurodegenerative diseases

Mesh:

Year:  2021        PMID: 33846881     DOI: 10.1007/s10072-021-05234-x

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  46 in total

1.  Carrier particle design for stabilization and isolation of drug nanoparticles.

Authors:  Teresa Tierney; Katalin Bodnár; Åke Rasmuson; Sarah Hudson
Journal:  Int J Pharm       Date:  2016-11-21       Impact factor: 5.875

2.  Effects of ZnO nanoparticles on intestinal function and structure in normal/high fat diet-fed rats and Caco-2 cells.

Authors:  Ebrahim Abbasi-Oshaghi; Fatemeh Mirzaei; Amir Mirzaei
Journal:  Nanomedicine (Lond)       Date:  2018-11-05       Impact factor: 5.307

3.  Alzheimer's disease amyloid beta peptides in vitro electrochemical oxidation.

Authors:  Teodor Adrian Enache; Ana Maria Oliveira-Brett
Journal:  Bioelectrochemistry       Date:  2016-11-05       Impact factor: 5.373

4.  Assessing validity of serum cystatin C for predicting metabolic syndrome.

Authors:  Zahra Asefy; MirMoosa Mirinejad; Hooshang Amirrasooli; Mohammad Tagikhani
Journal:  Pak J Biol Sci       Date:  2014-04

Review 5.  Cognitive reserve in ageing and Alzheimer's disease.

Authors:  Yaakov Stern
Journal:  Lancet Neurol       Date:  2012-11       Impact factor: 44.182

Review 6.  TLRs and chronic inflammation.

Authors:  Caroline Ospelt; Steffen Gay
Journal:  Int J Biochem Cell Biol       Date:  2009-10-17       Impact factor: 5.085

Review 7.  The role of selectins in inflammation and disease.

Authors:  Klaus Ley
Journal:  Trends Mol Med       Date:  2003-06       Impact factor: 11.951

Review 8.  Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation.

Authors:  Sonia Villapol
Journal:  Cell Mol Neurobiol       Date:  2017-10-03       Impact factor: 5.046

Review 9.  Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude Wischik; Patrick R Hof
Journal:  Biomolecules       Date:  2016-01-06

10.  Role of spinal microglia in rat models of peripheral nerve injury and inflammation.

Authors:  Anna K Clark; Clive Gentry; Elizabeth J Bradbury; Stephen B McMahon; Marzia Malcangio
Journal:  Eur J Pain       Date:  2006-03-20       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.